These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38751679)

  • 1. Breast surgery after neoadjuvant systemic therapy.
    Pawloski KR; Barrio AV
    Transl Breast Cancer Res; 2024; 5():13. PubMed ID: 38751679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
    Petruolo O; Sevilimedu V; Montagna G; Le T; Morrow M; Barrio AV
    Ann Surg Oncol; 2021 Jan; 28(1):287-294. PubMed ID: 32514804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
    Mamtani A; Sevilimedu V; Le T; Morrow M; Barrio AV
    Cancer; 2022 Feb; 128(3):471-478. PubMed ID: 34597420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
    Verdial FC; Mamtani A; Pawloski KR; Sevilimedu V; D'Alfonso TM; Zhang H; Gemignani ML; Barrio AV; Morrow M; Tadros AB
    Ann Surg Oncol; 2022 Jun; 29(6):3810-3819. PubMed ID: 35246810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
    Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
    BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Effective is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery?
    Montagna G; Sevilimedu V; Fornier M; Jhaveri K; Morrow M; Pilewskie ML
    Ann Surg Oncol; 2020 Nov; 27(12):4702-4710. PubMed ID: 32839900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative Standards in Surgery of the Breast after Neoadjuvant Systemic Therapy.
    Hadar T; Koretz M; Nawass M; Allweis TM
    Breast Care (Basel); 2021 Dec; 16(6):590-597. PubMed ID: 35087362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
    Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
    Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
    Boughey JC; McCall LM; Ballman KV; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Flippo-Morton T; Hunt KK
    Ann Surg; 2014 Oct; 260(4):608-14; discussion 614-6. PubMed ID: 25203877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy.
    Gulis K; Ellbrant J; Svensjö T; Skarping I; Vallon-Christersson J; Loman N; Bendahl PO; Rydén L
    Eur J Surg Oncol; 2023 Jul; 49(7):1189-1195. PubMed ID: 37019807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype
    Kim HS; Yoo TK; Park WC; Chae BJ
    J Breast Cancer; 2019 Sep; 22(3):412-424. PubMed ID: 31598341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.
    Freeman JQ; Shubeck SP; Chen N; Yarlagadda SR; Nanda R; Huo D; Howard FM
    Ann Surg Oncol; 2024 Dec; 31(13):8829-8842. PubMed ID: 39251516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome.
    van Hemert A; van Loevezijn AA; Bosman A; Vlahu CA; Loo CE; Peeters MTFDV; van Duijnhoven FH; van der Ploeg IMC
    Breast Cancer Res Treat; 2024 Apr; 204(3):497-507. PubMed ID: 38189904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy.
    Chou HH; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Yu MC; Lo YF; Dabora MA; Chang HK; Lin YC; Ueng SH; Chen SC
    Biomed J; 2019 Feb; 42(1):66-74. PubMed ID: 30987708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
    Golshan M; Cirrincione CT; Sikov WM; Carey LA; Berry DA; Overmoyer B; Henry NL; Somlo G; Port E; Burstein HJ; Hudis C; Winer E; Ollila DW;
    Breast Cancer Res Treat; 2016 Nov; 160(2):297-304. PubMed ID: 27704226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.
    Cen C; Chun J; Kaplowitz E; Axelrod D; Shapiro R; Guth A; Schnabel F
    Ann Surg Oncol; 2021 Sep; 28(9):5142-5148. PubMed ID: 33635409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.
    van der Noordaa MEM; Ioan I; Rutgers EJ; van Werkhoven E; Loo CE; Voorthuis R; Wesseling J; van Urk J; Wiersma T; Dezentje V; Vrancken Peeters MTFD; van Duijnhoven FH
    Ann Surg Oncol; 2021 Nov; 28(12):7383-7394. PubMed ID: 33978889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of breast imaging parameters obtained from
    Grapin M; Coutant C; Riedinger JM; Ladoire S; Brunotte F; Cochet A; Humbert O
    Eur J Radiol; 2019 Apr; 113():81-88. PubMed ID: 30927964
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.